Physician profile
Ali Afrassiabi
NPI 1760486286
$1,861.11
in general payments reported to CMS, 2019-2025
12 companies · $722 in 2025
The $722 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $42.84 · 2021: $78.61 · 2022: $295 · 2023: $113 · 2024: $466 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,238.62 | 2021-2025 | Idosetr, Istent Infinite, Idose |
| Allergan, INC. | $126.75 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $98.28 | 2021-2025 | Bridion |
| Bausch & Lomb Americas INC. | $94.71 | 2023-2024 | Vyzulta, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $87.25 | 2019-2025 | Tecnis Simplicity, Catalys System |
| Avanos Medical | $53.70 | 2024 | Pnb and Accessories |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.95 | 2019 | |
| Dompe US, INC. | $32.45 | 2024 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $28.10 | 2022 | |
| Rayner Intraocular Lenses Limited | $25.18 | 2024 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Abbvie INC. | $18.53 | 2022 | |
| Alcon Vision LLC | $14.59 | 2025 | Rocklatan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Afrassiabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.